Insys Therapeutics Inc. (INSY) Stock Price & Overview

NASDAQ:INSY

0.2911

0 (-1.36%)

At close: Jun 18, 2019

0.255

-0.04 (-12.4%)

After Hours: 6/18/2019, 8:51:28 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of INSY is 0.2911 null. Today INSY is down by -1.36%. In the past month the price decreased by -69.62%. In the past year, price decreased by -96.43%.

INSY Key Statistics

52-Week Range0.142 - 11.65

1-Month Range0.142 - 1.9

Market Cap: 21.707M
P/E: N/A
Fwd P/E: N/A
EPS (TTM): -1.74
Dividend Yield: N/A

INSY Stock Performance

Today

-1.36%

1 Week

+105.00%

1 Month

-69.62%

3 Months

-93.40%

Longer-term

6 Months -92.09%

1 Year -96.43%

2 Years N/A

3 Years N/A

5 Years N/A

10 Years N/A

INSY Stock Chart

Insys Therapeutics Inc. / INSY Daily stock chart

INSY Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to INSY. When comparing the yearly performance of all stocks, INSY is a bad performer in the overall market: 99.94% of all stocks are doing better.

Chartmill TA Rating

Chartmill Setup Rating

INSY Full Technical Analysis Report

INSY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to INSY. INSY may be in some trouble as it scores bad on both profitability and health.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

INSY Full Fundamental Analysis Report

INSY Earnings

Next Earnings DateN/A

Last Earnings DateN/A

INSY Earnings History

INSY Forecast & Estimates

Analysts

Analysts80

Price TargetN/A

EPS Next Y-11.51%

Revenue Next YearN/A

INSY Forecast & Estimates

INSY Financial Highlights

Over the last trailing twelve months INSY reported a non-GAAP Earnings per Share(EPS) of -1.7400000000000002. The EPS decreased by -145.07% compared to the year before.

Income Statements

Revenue(TTM)65.80M

Net Income(TTM)-227.98M

		Industry Rank	Sector Rank
PM (TTM)	-346.48%
ROA	-132.09%
ROE	139.25%
Debt/Equity	-0.07

Chartmill High Growth Momentum

EPS Q2Q%-163.64%

Sales Q2Q%-68.09%

EPS 1Y (TTM)-145.07%

Revenue 1Y (TTM)-48.85%

INSY financials

INSY Ownership

Ownership

Inst Owners0%

Shares74.57M

Float26.10M

Ins Owners1.26%

Short Float %N/A

Short RatioN/A

INSY Ownership

About INSY

Company Profile

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.

Company Info

Insys Therapeutics Inc.

1333 S. Spectrum Blvd Suite 100

Chandler AZ 85286

CEO: Saeed Motahari

Phone: 480-500-3127

Insys Therapeutics Inc. / INSY FAQ

What does Insys Therapeutics Inc. do?

What is the current price of INSY stock?

The current stock price of INSY is 0.2911 null. The price decreased by -1.36% in the last trading session.

Does INSY stock pay dividends?

INSY does not pay a dividend.

What is the ChartMill rating of Insys Therapeutics Inc. stock?

INSY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.

Where is Insys Therapeutics Inc. (INSY) stock traded?

INSY stock is listed on the Nasdaq exchange.

Who owns Insys Therapeutics Inc.?

You can find the ownership structure of Insys Therapeutics Inc. (INSY) on the Ownership tab.